Historique
Auteur G. MARTINOTTI
Documents disponibles écrits par cet auteur (12)
Ajouter le résultat à votre sélection Affiner la recherche
L. JANIRI ; G. MARTINOTTI ; DARIO T. ; REINA D. ; PAPARELLO F. ; G. POZZI ; G. ADDOLORATO ; M. DI GIANNANTONIO ; DE RISIO S. | 2005
Dans Neuropsychobiology (Vol.52, n°1, February 2005) Article : PériodiqueAnhedonia is a condition in which the capacity of experiencing pleasure is totally or partially lost, frequently occurring in mood disorders, as a negative symptom in schizophrenia, and in substance use disorders. In order to test a set of instr[...]
M. ARGOTE ; G. SESCOUSSE ; J. BRUNELIN ; G. BAUDIN ; M. P. SCHAUB ; R. RABIN ; T. SCHNELL ; P. A. RINGEN ; O. A. ANDREASSEN ; J. M. ADDINGTON ; P. BRAMBILLA ; G. DELVECCHIO ; A. BECHDOLF ; T. WOBROCK ; T. SCHNEIDER-AXMANN ; D. HERZIG ; C. MOHR ; R. VILA-BADIA ; J. U. RODIE ; J. MALLET ; V. RICCI ; G. MARTINOTTI ; K. KNIZKOVA ; M. RODRIGUEZ ; J. COOKEY ; P. TIBBO ; F. SCHEFFLER ; L. ASMAL ; C. GARCIA-RIZO ; S. AMORETTI ; C. HUBER ; H. THIBEAU ; E. KLINE ; E. FAKRA ; R. JARDRI ; M. NOURREDINE ; B. ROLLAND | 2023
Dans EClinicalMedicine (Vol.64, October 2023) Article : PériodiqueFRANÇAIS : Des chercheurs de plusieurs pays européens, américains et africains ont réalisé une méta-analyse sur l'association entre la consommation de cannabis et la schizophrénie. Ils ont conclu que les résultats ne permettaient pas de détermi[...]
J. M. CORKERY ; F. SCHIFANO ; G. MARTINOTTI | 2020
Dans British Journal of Clinical Pharmacology (Vol.86, n°3, March 2020) Article : PériodiqueNovel psychoactive substances (NPS), especially those newly created, are largely an unknown quantity, particularly in terms of their potential serious adverse effects. This means that policy-makers and clinicians are under-informed about appropr[...]
F. SCHIFANO ; LEONI M. ; G. MARTINOTTI ; S. RAWAF ; ROVETTO F. | 2003
Dans CyberPsychology and Behavior (Vol.6, n°4, 2003) Article : PériodiqueWhat do therapy and cybertherapy need to take into account to be effective for the treatment of drug-related disorders? The Psychonaut 2002 project is aimed to create a new and updated Web-based tool, which will be based on evolving drug scenari[...]
E. CINOSI ; O. CORAZZA ; R. SANTACROCE ; M. LUPI ; T. ACCIAVATTI ; G. MARTINOTTI ; M. DI GIANNANTONIO | 2014
Dans BioMed Research International (Vol.2014, 2014) Article : PériodiqueINTRODUCTION: The number of new psychoactive substances (NPS) advertised for sale online is constantly increasing and it has become a phenomenon of global concern. Among NPS, Camfetamine has been rediscovered as recreational drug in 2011. Very l[...]
G. MARTINOTTI ; C. MERINO DEL VILLAR ; R. GIORGETTI ; F. SCHIFANO ; M. DI GIANNANTONIO | 2019
Chapitre
G. MARTINOTTI ; G. DI IORIO ; D. TEDESCHI ; D. DE BERARDIS ; C. NIOLU ; L. JANIRI ; M. DI GIANNANTONIO | 2011
Dans American Journal of Drug and Alcohol Abuse (Vol.37, n°2, 2011) Article : PériodiqueBackground: It is difficult to establish whether people who are prone to psychosis are drawn to cannabis use or whether cannabis use truly increases the incidence of psychotic experiences. Objectives: The aim of our study was to evaluate, in a[...]
A. MIULI ; G. STIGLIANO ; A. LALLI ; M. COLADONATO ; L. D'ANGELO ; F. ESPOSITO ; C. CAPPELLO ; M. PETTORRUSO ; G. MARTINOTTI ; F. SCHIFANO ; M. DI GIANNANTONIO | 2020
Dans Journal of Psychoactive Drugs (Vol.52, n°5, November-December 2020) Article : PériodiqueIn the early 1990s, several studies reported the misuse of codeine and promethazine hydrochloride cough syrup. Since then, the combination of this pharmaceutical, together with sprite or alcohol, known on the streets as "purple drank" or "lean",[...]
O. CORAZZA ; G. VALERIANI ; F. S. BERSANI ; J. CORKERY ; G. MARTINOTTI ; G. BERSANI ; F. SCHIFANO | 2014
Dans Journal of Psychoactive Drugs (Vol.46, n°4, September-October 2014) Article : PériodiqueIntroduction: Novel Psychoactive Substances (NPSs) are often sold online as "legal" and "safer" alternatives to International Controlled Drugs (ICDs) with captivating marketing strategies. Our aim was to review and summarize such strategies in t[...]
A. E. VENTO ; G. MARTINOTTI ; E. CINOSI ; M. LUPI ; T. ACCIAVATTI ; D. CARRUS ; R. SANTACROCE ; E. CHILLEMI ; L. BONIFACI ; M. DI GIANNANTONIO ; O. CORAZZA ; F. SCHIFANO | 2014
Dans BioMed Research International (Vol.2014, 2014) Article : PériodiqueOBJECTIVE: Over the last few years, a wide number of unregulated substances have been marketed on the Web and in smart and head shops; they are usually advertised as legal alternatives to commonly known drugs and are defined as "smart drugs," "l[...]
O. CORAZZA ; F. S. BERSANI ; R. BRUNORO ; G. VALERIANI ; G. MARTINOTTI ; F. SCHIFANO | 2014
Dans Substance Use and Misuse (Vol.49, n°14, 2014) Article : PériodiqueINTRODUCTION: Performance and image-enhancing drugs (PIEDs), also known as "lifestyle drugs," are increasingly sold on the Internet to enhance cognitive as well as sexual, muscular, attentive, and other natural capacities. Our analysis focuses o[...]
L. JANIRI ; G. MARTINOTTI ; DARIO T. ; F. SCHIFANO ; BRIA P. | 2007
Dans Substance Use and Misuse (Vol.42 n°6, 2007) Article : PériodiqueFRANÇAIS : Dans une étude comparative croisée, 28 joueurs pathologiques probables (PPJs), 32 joueurs non pathologiques (non-PJs) et 65 contrôles ont consenti à subir un test de personnalité de Cloninger appelé "Temperament and Character Invento[...]
